QUEEN MARY UNIVERSITY OF LONDON
- Country
- π¬π§United Kingdom
- Ownership
- Private
- Established
- 1882-01-08
- Employees
- 1K
- Market Cap
- -
- Website
- http://www.qmul.ac.uk
Keloid Scarring: Treatment and Pathophysiology
- Conditions
- Interventions
- First Posted Date
- 2011-02-14
- Last Posted Date
- 2023-09-18
- Lead Sponsor
- Queen Mary University of London
- Registration Number
- NCT01295099
- Locations
- π¬π§
Barts and the London NHS Trust, London, UK, United Kingdom
Monoclonal Antibodies in Recurrent or Refractory B Cell Acute Lymphoblastic Leukaemia (ALL) (MARALL)
- First Posted Date
- 2011-01-19
- Last Posted Date
- 2014-07-14
- Lead Sponsor
- Queen Mary University of London
- Target Recruit Count
- 55
- Registration Number
- NCT01279707
- Locations
- π¬π§
Newcastle University, Newcastle, United Kingdom
π¬π§University Hospitals Birmingham NHS Foundation, Birmingham, United Kingdom
π¬π§University of Bristol Foundation Trust, Bristol, United Kingdom
De-nicotinised Cigarettes Study
- Conditions
- Interventions
- First Posted Date
- 2010-11-30
- Last Posted Date
- 2012-07-17
- Lead Sponsor
- Queen Mary University of London
- Target Recruit Count
- 200
- Registration Number
- NCT01250301
- Locations
- π¬π§
Tobacco Dependence Research Unit, London, United Kingdom
The Acute Effect of Beetroot Juice in Normal and Hypertensive Subjects
- Conditions
- Interventions
- First Posted Date
- 2010-11-09
- Last Posted Date
- 2011-08-08
- Lead Sponsor
- Queen Mary University of London
- Target Recruit Count
- 15
- Registration Number
- NCT01236872
- Locations
- π¬π§
Queen Mary University London, London, United Kingdom
Tailoring Varenicline to Individual Needs (TVIN Study)
- Conditions
- Interventions
- First Posted Date
- 2010-09-21
- Last Posted Date
- 2013-04-25
- Lead Sponsor
- Queen Mary University of London
- Target Recruit Count
- 200
- Registration Number
- NCT01206010
- Locations
- π¬π§
Tobacco Dependence Research and Treatment Unit, London, United Kingdom
European Surgical Outcomes Study
- Conditions
- First Posted Date
- 2010-09-16
- Last Posted Date
- 2012-09-05
- Lead Sponsor
- Queen Mary University of London
- Target Recruit Count
- 46985
- Registration Number
- NCT01203605
- Locations
- π¬π§
National co-ordinator, London, United Kingdom
Combination of Nicotine Replacement Therapy (NRT) and Varenicline to Increase Cessation of Tobacco (CONVICT Study)
- Conditions
- Interventions
- First Posted Date
- 2010-08-19
- Last Posted Date
- 2012-10-11
- Lead Sponsor
- Queen Mary University of London
- Target Recruit Count
- 117
- Registration Number
- NCT01184664
- Locations
- π¬π§
Tobacco Dependence Research Unit, London, United Kingdom
π¬π§Tobacco Dependence Research and Treatment Unit, London, United Kingdom
Wheeze and Intermittent Treatment
- First Posted Date
- 2010-06-11
- Last Posted Date
- 2014-04-29
- Lead Sponsor
- Queen Mary University of London
- Target Recruit Count
- 1358
- Registration Number
- NCT01142505
- Locations
- π¬π§
Barts and the London NHS Trust, London, United Kingdom
The Effects of C-type Natriuretic Peptide on Human Forearm Blood Vessels
- Conditions
- Interventions
- First Posted Date
- 2010-02-25
- Last Posted Date
- 2020-05-05
- Lead Sponsor
- Queen Mary University of London
- Registration Number
- NCT01075776
- Locations
- π¬π§
Queen Mary University London, London, United Kingdom
A Double Blind Randomised Study of Lapatinib and Placebo in Metastatic TCC of the Urothelium
- First Posted Date
- 2009-07-30
- Last Posted Date
- 2015-04-15
- Lead Sponsor
- Queen Mary University of London
- Target Recruit Count
- 204
- Registration Number
- NCT00949455
- Locations
- π¬π§
Barts and the London NHS Trust, London, England, United Kingdom
π¬π§Mid Essex NHS Trust - Broomfield Hospital, Chelmsford, United Kingdom
π¬π§Cambridge University Hospitals NHS Trust - Addenbrooke's Hospital, Cambridge, United Kingdom